2.05 USD
↗ 0.01 (0.54%)LIVE (AS OF 01:04 PM EDT)
Sera Prognostics, Inc. Class A Common Stock
SERANASDAQ • USD
Market: OPEN
Shares of Sera Prognostics, Inc. Class A Common Stock (SERA) are trading at $2.05. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place SERA at a fair price relative to peers.
Technical & fundamental data as of Oct 26, 2026.
Open?$2.04
High?$2.10
Low?$2.02
Prev. Close?$2.04
Volume?900
Avg. Volume?15.9K
VWAP?$2.04
Rel. Volume?0.06x
Bid / Ask
Bid?$1.74 × 100
Ask?$2.41 × 100
Spread?$0.67
Midpoint?$2.08
Valuation & Ratios
Market Cap?80.5M
Shares Out?38.5M
Float?32.1M
Float %?83.5%
P/E Ratio?N/A
P/B Ratio?1.36
EPS?-$0.84
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
Themes
Employees
72
Market Cap
80.1M
Industry
SERVICES-MEDICAL LABORATORIES
Website
Listed
2021-07-15
Address
2749 E. PARLEYS WAY
SALT LAKE CITY, UT 84109
Phone: (801) 990-0520
SALT LAKE CITY, UT 84109
Phone: (801) 990-0520
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?0
Momentum?35
Short Sent.?65
Piotroski F-Score?4/9Mixed
Altman Z-Score?-10.38Distress
Confidence?52%Low
Short InterestVery High
Short % of Float?0.69%Low
Short Interest?222.7K
Days to Cover?21.5
Free Float32.1M
Avg Daily Volume10.3K
Settlement Date2026-10-15
Financial Health
Current Ratio?1.98Adequate
Quick Ratio?1.98Adequate
Cash Ratio?0.18Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.36CHEAP▾
Peers100
S&P90
P/S?1,149.67HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-2.1CHEAP▾
S&P97
EV/Sales?1,086.84HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-56.0%WEAK▾
S&P3
ROA?-38.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-28148000
Enterprise Value?$76.1M
Fundamentals ratios updated end of day